Medsafe issues alert on unapproved peptides
Medsafe, New Zealand’s medicines and medical devices safety authority, has issued an alert on the risks of unapproved peptide products.
The alert provides the latest information on the serious health risks associated with these illegally imported products, where the contents, safety and quality are unknown.
The availability and use of unapproved peptide products continues to increase both in New Zealand and internationally, putting put undue pressure on hospital systems.
Last modified: